Due to the limited data, it should be avoided by anyone who is pregnant, breastfeeding, or undergoing active cancer treatment
The estimated half-life of CJC-1295 was 5.88.1 days
For instance, studies suggest that out of its 191 amino acid structure the N-terminal region exhibits an insulin-potentiating action, while amino acids 108 - 129 of hGH were found to evoke high mitogenic responses
This shifts the receptor balance in a more lipolytic direction, potentially explaining improvements in stubborn fat deposits that have not responded to other interventions
What the trial data shows
When to Choose AOD-9604: AOD-9604 is particularly well-suited for individuals seeking selective fat metabolism enhancement without broader hormonal changes, those who have not responded adequately to diet and exercise alone for stubborn fat reduction, individuals who cannot tolerate or are contraindicated for GLP-1 agonists or growth hormone, athletes needing body composition improvement without affecting glucose regulation or hormone levels, and those preferring a well-researched peptide with established safety data from clinical trials